112 related articles for article (PubMed ID: 9804454)
1. Quantification of device adherent, circulating, and organ pool of thrombin and fibrinogen after cardiopulmonary bypass in a pig model.
Dewanjee MK; Wu SM; Kapadvanjwala M; Hsu LC
ASAIO J; 1998; 44(5):M374-9. PubMed ID: 9804454
[TBL] [Abstract][Full Text] [Related]
2. Emboli from an extraluminal blood flow hollow fiber oxygenator with and without an arterial filter during cardiopulmonary bypass in a pig model.
Dewanjee MK; Wu SM; Kapadvanjwala M; De D; Dewanjee S; Gonzalez L; Novak S; Hsu LC; Perryman RA; Duncan RC; Serafini AN; Sfakianakis GN; Horton AF
ASAIO J; 1996; 42(6):1010-8. PubMed ID: 8959277
[TBL] [Abstract][Full Text] [Related]
3. A new method for quantitation of platelet microthrombi and microemboli from cardiopulmonary bypass in organs using 111In labeled platelets.
Dewanjee MK; Zhai P; Hsu LC; Twardock AR
ASAIO J; 1997; 43(5):M701-5. PubMed ID: 9360137
[TBL] [Abstract][Full Text] [Related]
4. Effect of Thoracotomy and Cardiopulmonary Bypass on Activated Platelet and Neutrophil Dynamics and Platelet Emboli in a Pig Model.
Dewanjee MK; Belinskiy V; Holland JF; Kapadvanjwala M; Wu SM; Novak S; Hsu LC; Sanchez J; Dewanjee S; Serafini AN; Duncan RC; Sfakianakis GN
J Thromb Thrombolysis; 1996; 3(3):195-208. PubMed ID: 10613983
[TBL] [Abstract][Full Text] [Related]
5. Effect of heparin reversal and fresh platelet transfusion on platelet emboli post-cardiopulmonary bypass in a pig model.
Dewanjee MK; Wu SM; Hsu LC
ASAIO J; 2000; 46(3):313-8. PubMed ID: 10826743
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Platelet Thrombi and Emboli by L-Arginine during Cardiopulmonary Bypass in a Pig Model.
Dewanjee MK; Wu SM; Kapadvanjwala M; De D; Dewanjee S; Novak S; Hsu LC; Perryman RA; Serafini AN; Sfakianakis GN; Duncan RC; Dietrich WD; Horton AF
J Thromb Thrombolysis; 1996; 3(4):343-360. PubMed ID: 10602564
[TBL] [Abstract][Full Text] [Related]
7. Reduction of neutrophil margination by L-arginine during hypothermic cardiopulmonary bypass in a pig model.
Dewanjee MK; Wu SM; De D; Nadkarni R; Gonzalez L; Dewanjee S; Novak S; Perryman RA; Serafini AN; Sfakianakis GN; Duncan RC; Dietrich WD; Ganz WI; Hsu LC
ASAIO J; 1996; 42(5):M661-6. PubMed ID: 8944963
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil dynamics and retention in lung, oxygenator, and arterial filter during cardiopulmonary bypass in a pig model.
Dewanjee MK; Palatianos GN; Kapadvanjwala M; Hsu LC; Novak S; Balantino G; Serafini AN; Dietrich WD; Sfakianakis GN
ASAIO J; 1994; 40(3):M547-53. PubMed ID: 8555575
[TBL] [Abstract][Full Text] [Related]
9. Rate constants of embolization and quantitation of emboli from the hollow-fiber oxygenator and arterial filter during cardiopulmonary bypass.
Dewanjee MK; Palatianos GM; Kapadvanjwala M; Novak S; Hsu LC; Serafini AN; Sfakianakis GN
ASAIO J; 1992; 38(3):M317-21. PubMed ID: 1457873
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
12. Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-II heparin-coated surfaces.
Palatianos GM; Dewanjee MK; Smith W; Novak S; Hsu LC; Kapadvanjwala M; Sfakianakis GN; Kaiser GA
ASAIO Trans; 1991; 37(4):620-2. PubMed ID: 1722689
[TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary bypass pumps and thrombin generation: what goes around comes around.
Brister SJ; Pelletier A; Fedorshyn J; Puchalski S; Buchanan MR
ASAIO J; 1998; 44(6):794-8. PubMed ID: 9831087
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary bypass with a surface-heparinized extracorporeal perfusion system.
Palatianos GM; Dewanjee MK; Kapadvanjwala M; Novak S; Sfakianakis GN; Kaiser GA
ASAIO Trans; 1990; 36(3):M476-9. PubMed ID: 2252729
[TBL] [Abstract][Full Text] [Related]
15. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
16. Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine model.
Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Rämö OJ; Petäjä J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):189-96. PubMed ID: 15282454
[TBL] [Abstract][Full Text] [Related]
17. Alterations of hemostasis associated with cardiopulmonary bypass.
Bick RL; Schmalhorst WR; Arbegast NR
Thromb Res; 1976 Mar; 8(3):285-302. PubMed ID: 131387
[No Abstract] [Full Text] [Related]
18. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
[TBL] [Abstract][Full Text] [Related]
20. Reversal of anticoagulation without protamine using a heparin removal device after cardiopulmonary bypass.
Vertress RA; Zwischenberger JB; McRea JC; Tao W; Kurusz M; Conti VR
ASAIO J; 1994; 40(3):M560-4. PubMed ID: 8555577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
